Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib + CPX-351 in Newly Diagnosed AML
NCT03844997Phase 2Completed
- Start
- Jun 2019
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in acute myeloid leukemia (AML). Started Jun 2019; status: completed.
02
Drugs
palbociclib
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03844997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03844997.